SCHEMBL26075396

SCHEMBL26075396

COCc1ccccc1-c1ccc(-c2cc(C=O)c3cc(C)ccc3n2)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 4/20 0.44
▸ KMT2A Q03164 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ S1PR1 P21453 1/20 0.39
▸ S1PR3 Q99500 1/20 0.39
▸ KDM4E B2RXH2 4/20 0.38
▸ ESR1 P03372 3/20 0.38
▸ ESR2 Q92731 3/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ GRM2 Q14416 1/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ HPGD P15428 3/20 0.38
▸ THRB P10828 3/20 0.38
▸ MAPT P10636 5/20 0.37
▸ LMNA P02545 4/20 0.37
▸ NPSR1 Q6W5P4 3/20 0.37
▸ HSP90AA1 P07900 3/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075919 0.86 KDM4E (0.56) DHODHKMT2APOLBS1PR1S1PR3
SCHEMBL26075401 0.85 DHODH (0.44) DHODHKMT2AKDM4EESR1ESR2
SCHEMBL26075388 0.84 DHODH (0.43) DHODHKMT2AKDM4EESR1ESR2
SCHEMBL26075310 0.82 DHODH (0.42) DHODHKMT2AS1PR1S1PR3ESR1
SCHEMBL26075441 0.81 ALDH1A1 (0.42) DHODHKMT2APOLBKDM4EESR1
SCHEMBL26075892 0.80 S1PR1 (0.41) DHODHS1PR1S1PR3ESR1ESR2
SCHEMBL26075408 0.80 DHODH (0.45) DHODHKMT2AKDM4EESR1ESR2
SCHEMBL26075337 0.80 MAPT (0.49) DHODHKDM4EGRM2ALDH1A1HPGD
SCHEMBL26075413 0.79 KDM4E (0.42) DHODHKMT2AKDM4EESR1ESR2
SCHEMBL26075395 0.79 ACP1 (0.39) DHODHS1PR1S1PR3ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885KMT2A 1314/4885POLB 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback